Re: RELMADA CEO Sergio Traversa files Form 4P for 200,000 shares
RELMADA THERAPEUTICS, INC. disclosed via Form 4P that CEO Sergio Traversa reported a transaction involving 200,000 shares at $4.14 each, totaling $828,000.
Story updates
11:42:41 AM UTC
SquawkNews
Sergio Traversa, a director and chief executive officer, purchased a total of 200,000 shares of common stock in two open-market transactions on September 9—10, 2026 at weighted-average prices of $4.18 for the September 9 purchases (range $4.15—$4.22) and $4.10 for the September 10 purchases (range…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.